title: Anxiety levels and perceived pain intensity during intravitreal injections.
authors.affiliation: Department of Ophthalmology, Meir Medical Center, Kfar Sava, Israel.|The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
authors.forename: Ori
authors.initials: O
authors.lastname: Segal
authors.affiliation: The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.|Department of Psychiatry, Geha Psychiatric Hospital, Petah Tikva, Israel.
authors.forename: Yael
authors.initials: Y
authors.lastname: Segal-Trivitz
authors.affiliation: Department of Ophthalmology, Meir Medical Center, Kfar Sava, Israel.|The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
authors.forename: Arie Y
authors.initials: AY
authors.lastname: Nemet
authors.affiliation: Department of Ophthalmology, Meir Medical Center, Kfar Sava, Israel.|The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
authors.forename: Perri
authors.initials: P
authors.lastname: Cohen
authors.affiliation: Department of Ophthalmology, Meir Medical Center, Kfar Sava, Israel.|The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
authors.forename: Noa
authors.initials: N
authors.lastname: Geffen
authors.affiliation: Department of Ophthalmology, Rambam Health Care Campus, Haifa, Israel.
authors.forename: Michael
authors.initials: M
authors.lastname: Mimouni
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D001007:Anxiety / Q000503:physiopathology*; D000068258:Bevacizumab / Q000627:therapeutic use; D058447:Eye Pain / Q000503:physiopathology*; D005260:Female; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D010147:Pain Measurement; D058748:Pain Perception / Q000502:physiology*; D011446:Prospective Studies; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab